Crotamiton/Diphenhydramine Hydrochloride/Vitamin E/Glycyrrhetinic Acid

克罗米通/盐酸苯海拉明/维生素E/甘草次酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCrotamiton/Diphenhydramine Hydrochloride/Vitamin E/Glycyrrhetinic Acid
Drug Alias Name复方克罗米通乳膏安夫康
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor inverse agonistsCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsHistamine H1 receptorPregnane X receptorCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes CrotamitonDiphenhydramine HydrochlorideVitamin E
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A